Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

A Look At Leqvio’s Lacklustre Launch

Novartis Cholesterol Drug Sales Still Stuck

26 Jul 2023

• By Kevin Grogan

Novartis — • Source: Novartis

Related Content

Novartis Bets On Buybacks Due To Limited M&A Options

18 Jul 2023

Eyebrows Raised As Roche Inks Cardiovascular Pact With Alnylam

24 Jul 2023

Novartis Gets Expansion For Earlier Use Of Leqvio

11 Jul 2023

All Systems Go For Novartis 'World-First' Leqvio Pact With England

01 Sep 2021

It's Time For Novartis To Put Its Leqvio Launch Strategy To The Test

22 Dec 2021

Buy-And-Bill A Bust For Novartis's Leqvio?

03 Jan 2023

Novartis Leqvio Launch Lags As COVID-19 Hinders England Access Scheme

02 Feb 2022

Related Companies

Novartis AG

Sanofi

Regeneron Pharmaceuticals, Inc.

Alnylam Pharmaceuticals Inc.

Additional Topics

Launches Clinical Trials Commercial Business Strategies Cardiovascular BioPharmaceutical

More from New Products

More from Scrip

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.